Clinical Trials
37 trialsHERIZON-GEA-01
Jazz Pharmaceuticals
KEYNOTE-585
Merck Sharp & Dohme LLC
KEYNOTE-585
Merck Sharp & Dohme LLC
KEYNOTE-859
Merck Sharp & Dohme LLC
MK-3475-811
Merck Sharp & Dohme LLC
PREVENT
Krankenhaus Nordwest
DIGEST
Taiho Oncology, Inc.
MK-3475-062
Merck Sharp & Dohme LLC
KEYNOTE-859
Merck Sharp & Dohme LLC
Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus
UNICANCER
JACOB
Hoffmann-La Roche
Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer
Seoul National University Hospital
Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer
Jonsson Comprehensive Cancer Center
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
Alliance for Clinical Trials in Oncology
Trial of Adjuvant Chemotherapy for Gastric Cancer
Asan Medical Center
Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal Metastasis
Nanfang Hospital, Southern Medical University
S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients
Sun Yat-sen University
Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
AVATAR
Hoffmann-La Roche
HELOISE
Hoffmann-La Roche
A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer
Hoffmann-La Roche
A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer
Japan Clinical Oncology Group
RILOMET-2
Amgen
RILOMET-1
Amgen
SOPP
Asan Medical Center
GASTRANOX
Thrombosis Research Institute
ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer
Hoffmann-La Roche
EXPAND
Merck KGaA, Darmstadt, Germany
Trial of Adjuvant Chemotherapy for Gastric Cancer
Asan Medical Center
Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
National Cancer Institute (NCI)
S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer
National Cancer Institute (NCI)
A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer
Trans Tasman Radiation Oncology Group
Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Taxotere New Indication - Gastric Cancer Treatment Registration Trial
Sanofi
Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric Adenocarcinoma
Samsung Medical Center
Trial of S-1 Plus Cisplatin in Gastric Cancer
Sun Yat-sen University
Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer
Taiho Pharmaceutical Co., Ltd.